Genesis Park is a 128,180 sq ft urban logistics scheme delivered and owned by Chancerygate and comprises 15 units ranging between 4,800 sq ft to 18,570 sq ft. It has a gross development value in excess of £23 million.
Deenova is a leading supplier of combined robotic and automation solutions for closed loop medications and medical devices traceability in the healthcare industry. In the UK, it works with the NHS to deliver pharmacy automation solutions which simplify the management of medications and medical devices.
-- Advertisement --
The company has signed a 15-year lease on the unit Deenova’s other UK office is located in East Sussex and also has offices in Italy, Spain, France and Malta.
In addition to the letting to Deenova, the unit has also been sold to Sandpiper Formulations Limited Pension Scheme for an undisclosed sum.
Unit 5, which has been let to healthcare company Fresenius Medical Care, has been acquired by Key West Holdings Limited for an undisclosed sum.
Two further units have been recently sold to owner occupiers at Genesis Park. Unit 1, which extends to 9,000 sq ft has been sold to Personal Homecare Pharmacy Limited and Unit 15, a unit of 10,000 sq ft, has been sold to F2 Medical Pension Scheme, both for undisclosed sums.
Five of the units at Genesis Park have now been sold, whilst the 6,750 sq ft Unit 11 has also been placed under offer on a freehold basis.
The nine remaining units at the development range from 4,800 sq ft to 9,875 sq ft and are available on a freehold or leasehold basis.
